Grifols have announced proof-of-concept data from its Chronos-PD programme, which uses AI, advanced proteomics and real-world ...

Richmond Pharmacology has appointed John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in ...

Understanding Neurodiversity Neurodivergence is often mistakenly equated solely with autism. As Prof. Kirby explains, it is a ...

Shionogi has dosed the first patients in the phase 2 clinical trial evaluating S-606001, a potential treatment for late-onset ...

Clasado Biosciences has appointed Sebastian Nummelin as APAC Regional Director. The move strengthens its commercial presence ...

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that ...

Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer ...

CNX Therapeutics has appointed David Flint as Chief Corporate Development Officer (CCDO). Flint is an experienced M&A and ...

Raguneprocel, a stem cell-based dopamine neuron replacement therapy for treating motor symptoms in Parkinson’s disease (PD), ...

Allergan Aesthetics, an AbbVie company, has launched a unified vocabulary to standardise how skin quality is discussed. The ...

There will be clear winners and losers across global stock markets should the US and Iran reach a peace deal this weekend, ...

AC Immune has entered into an agreement with Eli Lilly (Lilly) to amend their 2018 licence and collaboration agreement to ...